InsiderTrades

Form 4 for RPRX Royalty Pharma plc

Accepted 2025-08-11 00:00:00 ET · period of report 2025-08-08 · accession 0001802768-25-000107 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-08-11 2025-08-08 RPRX Norden Gregory Dir C - Cnv Deriv $0.00 +144.7K 228.3K +173% $0
D 2025-08-11 2025-08-11 RPRX Norden Gregory Dir S - Sale $36.23 -33.5K 194.8K -15% -$1.21M
D 2025-08-11 2025-08-08 RPRX Norden Gregory Dir C - Cnv Deriv $0.00 -14.5K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Ordinary Shares 2025-08-08 C A 144,660 $0.00 228,348 D — —
2 Common Class A Ordinary Shares 2025-08-11 S D 33,500 $36.23 194,848 D — — (F2) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.10 to $36.40 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3 Derivative LP interests in RPI US Partners 2019, LP 2025-08-08 C D 14,466 $0.00 0 D $0.00 · — to — 144,660 Class A Ordinary Shares (F3) Represents limited partnership interests in RPI US Partners 2019, LP ("RPI US LP Interests"). Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged upon such exchange for one Class A Ordinary Share of the Issuer for no additional value.